Page last updated: 2024-10-26

stallimycin and Endotoxemia

stallimycin has been researched along with Endotoxemia in 2 studies

Endotoxemia: A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baron, RM2
Lopez-Guzman, S1
Riascos, DF1
Macias, AA2
Layne, MD2
Cheng, G1
Harris, C1
Chung, SW1
Reeves, R1
von Andrian, UH1
Perrella, MA2
Carvajal, IM1
Liu, X1
Okabe, RO1
Fredenburgh, LE1
Chen, YH1
Ejima, K1

Other Studies

2 other studies available for stallimycin and Endotoxemia

ArticleYear
Distamycin A inhibits HMGA1-binding to the P-selectin promoter and attenuates lung and liver inflammation during murine endotoxemia.
    PloS one, 2010, May-14, Volume: 5, Issue:5

    Topics: Animals; AT Rich Sequence; Cattle; Cell Communication; Cytokines; Distamycins; Endothelial Cells; En

2010
Reduction of nitric oxide synthase 2 expression by distamycin A improves survival from endotoxemia.
    Journal of immunology (Baltimore, Md. : 1950), 2004, Sep-15, Volume: 173, Issue:6

    Topics: Animals; Cell Line; Cells, Cultured; Disease Models, Animal; Distamycins; DNA-Binding Proteins; Endo

2004